Use este identificador para citar ou linkar para este item: https://ri.ufs.br/jspui/handle/riufs/24393
Tipo de Documento: Artigo
Título: Determinants of intensive insulin therapeutic regimens in patients with type 1 diabetes: data from a nationwide multicenter survey in Brazil
Autor(es): Gomes, Marilia Brito
Negrato, Carlos Antônio
Cobas, Roberta
Tannus, Lucianne Righeti Monteiro
Gonçalves, Paolla Ribeiro
Silva, Pedro Carlos Barreto da
Carneiro, João Regis Ivar
Matheus, Alessandra Saldanha Mattos
Dib, Sergio Atala
Azevedo, Mirela Jobim
Nery, Márcia
Rodacki, Melanie
Zajdenverg, Lenita
Montenegro Junior, Renan Magalhães
Sepulveda, Janice
Calliari, Luis Eduardo
Jezini, Deborah
Braga, Neuza
Luescher, Jorge Luiz
Berardo, Renata Szundy
Arruda-Marques, Maria Carmo
Noronha, Renata M.
Manna, Thais Della
Salvodelli, Roberta
Penha, Fernanda G.
Foss, Milton Cesar
Freitas, Maria Cristina Foss de
Pires, Antônio C.
Robles, Fernando Cesar
Guedes, Maria de Fátima S.
Dualib, Patricia Medici
Silva, Saulo C.
Sampaio, Emerson
Rea, Rosangela
Faria, Ana Cristina R.
Tschiedel, Balduino
Lavigne, Suzana
Canani, Luis Henrique
Zucatti, Alessandra T.
Coral, Marisa Helena Cesar
Pereira, Daniela Aline
Araujo, Luiz Antonio
Tolentino, Monica
Pedrosa, Hermelinda Cordeiro
Prado, Flaviane A.
Rassi, Nelson
Araujo, Leticia B.
Fonseca, Reine Marie Chaves
Guedes, Alexis D.
Matos, Odelissa S.
Palma, Catia C.
Azulay, Rossana
Costa e Forti, Adriana
Façanha, Cristina
Montenegro, Ana Paula
Melo, Naira Horta
Rezende, Karla Freire
Ramos, Alberto
Felicio, João Soares
Santos, Flavia Marques
Data do documento: 2014
Resumo: Background: To evaluate the determinants of intensive insulin regimens (ITs) in patients with type 1 diabetes (T1D). Methods: This multicenter study was conducted between December 2008 and December 2010 in 28 public clinics in 20 Brazilian cities. Data were obtained from 3,591 patients (56.0% female, 57.1% Caucasian). Insulin regimens were classified as follows: group 1, conventional therapy (CT) (intermediate human insulin, one to two injections daily); group 2 (three or more insulin injections of intermediate plus regular human insulin); group 3 (three or more insulin injections of intermediate human insulin plus short-acting insulin analogues); group 4, basal-bolus (one or two insulin injections of long-acting plus short-acting insulin analogues or regular insulin); and group 5, basal-bolus with continuous subcutaneous insulin infusion (CSII). Groups 2 to 5 were considered IT groups. Results: We obtained complete data from 2,961 patients. Combined intermediate plus regular human insulin was the most used therapeutic regimen. CSII was used by 37 (1.2%) patients and IT by 2,669 (90.2%) patients. More patients on IT performed self-monitoring of blood glucose and were treated at the tertiary care level compared to CT patients (p < 0.001). The majority of patients from all groups had HbA1c levels above the target. Overweight or obesity was not associated with insulin regimen. Logistic regression analysis showed that economic status, age, ethnicity, and level of care were associated with IT (p < 0.001). Conclusions: Given the prevalence of intensive treatment for T1D in Brazil, more effective therapeutic strategies are needed for long term-health benefits.
Palavras-chave: Type 1 diabetes
Chronic complications
Insulin regimens
Brazil
ISSN: 1758-5996
Parte de : Diabetology and metabolic syndrome
Idioma: eng
Instituição/Editora: BioMed Central
Citação: GOMES, M. B. et al. Determinants of intensive insulin therapeutic regimens in patients with type 1 diabetes: data from a nationwide multicenter survey in Brazil. Diabetology and metabolic syndrome, London, v. 6, n. 67, 2014. Disponível em: https://link.springer.com/article/10.1186/1758-5996-6-67. Acesso em: 26 jan. 2026.
Licença: Creative Commons Atribuição 4.0 Internacional (CC BY 4.0)
Identificador: https://doi.org/10.1186/1758-5996-6-67
URI: https://ri.ufs.br/jspui/handle/riufs/24393
Aparece nas coleções:DME - Artigos de periódicos

Arquivos associados a este item:
Arquivo Descrição TamanhoFormato 
DeterminantsIntenseInsulinTherapeuticRegimens.pdf306,93 kBAdobe PDFThumbnail
Visualizar/Abrir


Os itens no repositório estão protegidos por copyright, com todos os direitos reservados, salvo quando é indicado o contrário.